|
nasdaq:gh
|
2644051
|
Apr 28th, 2024 12:00AM
|
Guardant Health
|
157K
|
2729
|
Open
|
|
Apr 27th, 2024 11:25PM
|
Apr 27th, 2024 11:25PM
|
Guardant Health is a leading precision medicine company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics.
Guardant Health has commercially launched Guardant360®, Guardant360 CDx, Guardant360 TissueNext™, Guardant360 Response™, and GuardantINFINITY™ tests for advanced-stage cancer patients, and Guardant Reveal™ for early-stage cancer patients. The Guardant Health screening portfolio, including the commercially launched Shield™ test, aims to address the needs of individuals eligible for cancer screening.
|
Open
|
|
Open
|
3100 Hanover Street
|
Palo Alto
|
California
|
US
|
94304
|
|
Guardant Health
|
|
|
|
nasdaq:gh
|
2644051
|
Apr 27th, 2024 12:00AM
|
Guardant Health
|
157K
|
2727
|
Open
|
|
Apr 26th, 2024 11:04PM
|
Apr 26th, 2024 11:04PM
|
Guardant Health is a leading precision medicine company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics.
Guardant Health has commercially launched Guardant360®, Guardant360 CDx, Guardant360 TissueNext™, Guardant360 Response™, and GuardantINFINITY™ tests for advanced-stage cancer patients, and Guardant Reveal™ for early-stage cancer patients. The Guardant Health screening portfolio, including the commercially launched Shield™ test, aims to address the needs of individuals eligible for cancer screening.
|
Open
|
|
Open
|
3100 Hanover Street
|
Palo Alto
|
California
|
US
|
94304
|
|
Guardant Health
|
|
|
|
nasdaq:gh
|
2644051
|
Apr 26th, 2024 12:00AM
|
Guardant Health
|
157K
|
2723
|
Open
|
|
Apr 25th, 2024 11:12PM
|
Apr 26th, 2024 08:32AM
|
Guardant Health is a leading precision medicine company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics.
Guardant Health has commercially launched Guardant360®, Guardant360 CDx, Guardant360 TissueNext™, Guardant360 Response™, and GuardantINFINITY™ tests for advanced-stage cancer patients, and Guardant Reveal™ for early-stage cancer patients. The Guardant Health screening portfolio, including the commercially launched Shield™ test, aims to address the needs of individuals eligible for cancer screening.
|
Open
|
|
Open
|
3100 Hanover Street
|
Palo Alto
|
California
|
US
|
94304
|
|
Guardant Health
|
|
|
|
nasdaq:gh
|
2644051
|
Apr 25th, 2024 12:00AM
|
Guardant Health
|
157K
|
2723
|
Open
|
|
Apr 24th, 2024 11:06PM
|
Apr 25th, 2024 06:45PM
|
Guardant Health is a leading precision medicine company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics.
Guardant Health has commercially launched Guardant360®, Guardant360 CDx, Guardant360 TissueNext™, Guardant360 Response™, and GuardantINFINITY™ tests for advanced-stage cancer patients, and Guardant Reveal™ for early-stage cancer patients. The Guardant Health screening portfolio, including the commercially launched Shield™ test, aims to address the needs of individuals eligible for cancer screening.
|
Open
|
|
Open
|
3100 Hanover Street
|
Palo Alto
|
California
|
US
|
94304
|
|
Guardant Health
|
|
|
|
nasdaq:gh
|
2644051
|
Apr 24th, 2024 12:00AM
|
Guardant Health
|
157K
|
2722
|
Open
|
|
Apr 23rd, 2024 11:12PM
|
Apr 24th, 2024 11:13AM
|
Guardant Health is a leading precision medicine company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics.
Guardant Health has commercially launched Guardant360®, Guardant360 CDx, Guardant360 TissueNext™, Guardant360 Response™, and GuardantINFINITY™ tests for advanced-stage cancer patients, and Guardant Reveal™ for early-stage cancer patients. The Guardant Health screening portfolio, including the commercially launched Shield™ test, aims to address the needs of individuals eligible for cancer screening.
|
Open
|
|
Open
|
3100 Hanover Street
|
Palo Alto
|
California
|
US
|
94304
|
|
Guardant Health
|
|
|
|
nasdaq:gh
|
2644051
|
Apr 23rd, 2024 12:00AM
|
Guardant Health
|
157K
|
2722
|
Open
|
|
Apr 22nd, 2024 10:54PM
|
Apr 23rd, 2024 04:46PM
|
Guardant Health is a leading precision medicine company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics.
Guardant Health has commercially launched Guardant360®, Guardant360 CDx, Guardant360 TissueNext™, Guardant360 Response™, and GuardantINFINITY™ tests for advanced-stage cancer patients, and Guardant Reveal™ for early-stage cancer patients. The Guardant Health screening portfolio, including the commercially launched Shield™ test, aims to address the needs of individuals eligible for cancer screening.
|
Open
|
|
Open
|
3100 Hanover Street
|
Palo Alto
|
California
|
US
|
94304
|
|
Guardant Health
|
|
|
|
nasdaq:gh
|
2644051
|
Apr 22nd, 2024 12:00AM
|
Guardant Health
|
156K
|
2722
|
Open
|
|
Apr 21st, 2024 11:33PM
|
Apr 21st, 2024 11:33PM
|
Guardant Health is a leading precision medicine company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics.
Guardant Health has commercially launched Guardant360®, Guardant360 CDx, Guardant360 TissueNext™, Guardant360 Response™, and GuardantINFINITY™ tests for advanced-stage cancer patients, and Guardant Reveal™ for early-stage cancer patients. The Guardant Health screening portfolio, including the commercially launched Shield™ test, aims to address the needs of individuals eligible for cancer screening.
|
Open
|
|
Open
|
3100 Hanover Street
|
Palo Alto
|
California
|
US
|
94304
|
|
Guardant Health
|
|
|
|
nasdaq:gh
|
2644051
|
Apr 21st, 2024 12:00AM
|
Guardant Health
|
156K
|
2718
|
Open
|
|
Apr 20th, 2024 11:30PM
|
Apr 20th, 2024 11:30PM
|
Guardant Health is a leading precision medicine company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics.
Guardant Health has commercially launched Guardant360®, Guardant360 CDx, Guardant360 TissueNext™, Guardant360 Response™, and GuardantINFINITY™ tests for advanced-stage cancer patients, and Guardant Reveal™ for early-stage cancer patients. The Guardant Health screening portfolio, including the commercially launched Shield™ test, aims to address the needs of individuals eligible for cancer screening.
|
Open
|
|
Open
|
3100 Hanover Street
|
Palo Alto
|
California
|
US
|
94304
|
|
Guardant Health
|
|
|
|
nasdaq:gh
|
2644051
|
Apr 20th, 2024 12:00AM
|
Guardant Health
|
156K
|
2718
|
Open
|
|
Apr 19th, 2024 11:28PM
|
Apr 20th, 2024 05:03PM
|
Guardant Health is a leading precision medicine company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics.
Guardant Health has commercially launched Guardant360®, Guardant360 CDx, Guardant360 TissueNext™, Guardant360 Response™, and GuardantINFINITY™ tests for advanced-stage cancer patients, and Guardant Reveal™ for early-stage cancer patients. The Guardant Health screening portfolio, including the commercially launched Shield™ test, aims to address the needs of individuals eligible for cancer screening.
|
Open
|
|
Open
|
3100 Hanover Street
|
Palo Alto
|
California
|
US
|
94304
|
|
Guardant Health
|
|
|
|
nasdaq:gh
|
2644051
|
Apr 19th, 2024 12:00AM
|
Guardant Health
|
156K
|
2714
|
Open
|
|
Apr 18th, 2024 11:34PM
|
Apr 18th, 2024 11:34PM
|
Guardant Health is a leading precision medicine company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics.
Guardant Health has commercially launched Guardant360®, Guardant360 CDx, Guardant360 TissueNext™, Guardant360 Response™, and GuardantINFINITY™ tests for advanced-stage cancer patients, and Guardant Reveal™ for early-stage cancer patients. The Guardant Health screening portfolio, including the commercially launched Shield™ test, aims to address the needs of individuals eligible for cancer screening.
|
Open
|
|
Open
|
3100 Hanover Street
|
Palo Alto
|
California
|
US
|
94304
|
|
Guardant Health
|
|
|